Decreased insulin binding of mononuclear leukocytes in diabetic patients with hyperlipidemia. 1980

K Hiramatsu, and H Sakai, and S Arimori

The effects of lipoproteins on 125I-insulin binding activity of mononuclear leukocytes were investigated in 22 diabetic patients and eight healthy adults. There was a significant negative relationship between insulin binding activity and levels of plasma beta-lipoprotein (r = 0.70, p < 0.01). The inhibition of insulin binding activity was also observed by in vitro addition of LDL to the assay system of insulin binding activity of mononuclear leukocytes. Double fluorescent staining techniques demonstrated that insulin receptors and LDL receptors are located very close to each other on the cell-surface. These results indicate that LDL intereferes with insulin binding activity in mononuclear leukocytes in vivo and in vitro, presumably because of the close localization of receptors for insulin and LDL on the cell surface. It is concluded that hyperlipoproteinemia is responsible for the decrease in insulin binding activity in diabetic patients.

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D011972 Receptor, Insulin A cell surface receptor for INSULIN. It comprises a tetramer of two alpha and two beta subunits which are derived from cleavage of a single precursor protein. The receptor contains an intrinsic TYROSINE KINASE domain that is located within the beta subunit. Activation of the receptor by INSULIN results in numerous metabolic changes including increased uptake of GLUCOSE into the liver, muscle, and ADIPOSE TISSUE. Insulin Receptor,Insulin Receptor Protein-Tyrosine Kinase,Insulin Receptor alpha Subunit,Insulin Receptor beta Subunit,Insulin Receptor alpha Chain,Insulin Receptor beta Chain,Insulin-Dependent Tyrosine Protein Kinase,Receptors, Insulin,Insulin Receptor Protein Tyrosine Kinase,Insulin Receptors
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

K Hiramatsu, and H Sakai, and S Arimori
January 1976, The American journal of medicine,
K Hiramatsu, and H Sakai, and S Arimori
July 1976, The Journal of clinical endocrinology and metabolism,
K Hiramatsu, and H Sakai, and S Arimori
June 1993, Acta endocrinologica,
K Hiramatsu, and H Sakai, and S Arimori
July 1980, The British journal of dermatology,
K Hiramatsu, and H Sakai, and S Arimori
May 1983, Acta endocrinologica,
K Hiramatsu, and H Sakai, and S Arimori
December 1974, The Journal of clinical investigation,
K Hiramatsu, and H Sakai, and S Arimori
September 1994, Brain, behavior, and immunity,
K Hiramatsu, and H Sakai, and S Arimori
August 1984, The Journal of clinical endocrinology and metabolism,
K Hiramatsu, and H Sakai, and S Arimori
August 1980, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
Copied contents to your clipboard!